Sight Sciences, Inc.
Clinical trials sponsored by Sight Sciences, Inc., explained in plain language.
-
Glaucoma device showdown ends early: only 10 patients enrolled
Disease control TerminatedThis study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both dev…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Eye pressure showdown: new device vs laser in glaucoma study
Disease control TerminatedThis study tested a new device called VISCO360 against a standard laser treatment (SLT) for lowering eye pressure in adults with open-angle glaucoma. The goal was to see which procedure is safer and more effective. The study was stopped early and included only 29 people who had a…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Warm compress showdown: can a new device beat the old way for dry eye?
Symptom relief TerminatedThis study compared the TearCare system, a device that applies heat to the eyelids, to standard warm compresses and lid massage for people with dry eye disease. The goal was to see if TearCare is safe and better at improving tear stability and reducing eye discomfort. The study p…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC